Literature DB >> 11240677

Prognostic factors in young women with endometrial carcinoma: a report of 20 cases and review of literature.

K. Yamazawa1, K. Seki, H. Matsui, M. Kihara, S. Sekiya.   

Abstract

We retrospectively reviewed the pathologic features of patients with endometrial carcinoma (EC) treated in our facility between 1989 and 1998. First, we identified the clincopathologic features of young women with EC and compared them with similar patients from the literature. Second, 148 EC patients were divided into two groups: group A (age</=45 years, n = 20) and B (age>45, n = 128). The mean follow-up periods were 65 months and 50 months in groups A and B, respectively. Group A patients had better disease-free survival (Kaplan-Meier method, P = 0.0283) compared to group B patients. The independent variables related to disease-free survival (Cox regression analysis) were age (P = 0.0001), stage (P = 0.0183), histology (P = 0.0011), and lymph node metastasis (P = 0.0007). The distribution of stage was significantly different between the two groups (Chi-square test, P = 0.0089). More group A patients (18 of 20; 90%) had early stage disease. There were no significant differences (Fisher's exact test) between the two groups in histology, grade, cervical involvement, vascular invasion, tumor size, ovarian malignancy, and lymph node metastasis. However, group A patients had a significant higher incidence of disease confined to the inner half of the myometrium than group B patients (P = 0.0004). We statistically confirmed that young women with EC had better outcome due to a significantly higher proportion of early stage disease and less myometrial invasion than older patients.

Entities:  

Year:  2000        PMID: 11240677     DOI: 10.1046/j.1525-1438.2000.010003212.x

Source DB:  PubMed          Journal:  Int J Gynecol Cancer        ISSN: 1048-891X            Impact factor:   3.437


  5 in total

1.  Racial disparities in young women with endometrial cancer.

Authors:  Barenya Mukerji; Caitlin Baptiste; Ling Chen; Ana I Tergas; June Y Hou; Cande V Ananth; Alfred I Neugut; Dawn L Hershman; Jason D Wright
Journal:  Gynecol Oncol       Date:  2018-01-05       Impact factor: 5.482

2.  Biomarkers in endometrial cancer: Possible clinical applications (Review).

Authors:  Kouji Banno; Iori Kisu; Megumi Yanokura; Kosuke Tsuji; Kenta Masuda; Arisa Ueki; Yusuke Kobayashi; Wataru Yamagami; Hiroyuki Nomura; Eiichiro Tominaga; Nobuyuki Susumu; Daisuke Aoki
Journal:  Oncol Lett       Date:  2012-03-26       Impact factor: 2.967

3.  Endometrium and ovarian cancer synchronous to endometriosis--a retrospective study of our experience of 7 years.

Authors:  Ioannis Grammatikakis; Stefanos Zervoudis; Nikolaos Evangelinakis; Vasiliki Tziortzioti
Journal:  J Med Life       Date:  2010 Jan-Mar

4.  Programmed Death Ligand 1: A Poor Prognostic Marker in Endometrial Carcinoma.

Authors:  Mianxin Chew; Yin Ping Wong; Norain Karim; Muaatamarulain Mustangin; Nurwardah Alfian; Geok Chin Tan
Journal:  Diagnostics (Basel)       Date:  2020-06-11

5.  Peritumoral Enhancement for the Evaluation of Myometrial Invasion in Low-Risk Endometrial Carcinoma on Dynamic Contrast-Enhanced MRI.

Authors:  Tingting Cui; Feng Shi; Bei Gu; Yanfang Jin; Jinsong Guo; Chao Zhang; Jie Ren; Yunlong Yue
Journal:  Front Oncol       Date:  2022-01-17       Impact factor: 6.244

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.